Plain-English translation of NCT03562052 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether low-dose lung scans can help find lung cancer early in people who smoke or used to smoke and have been exposed to cancer-causing chemicals in their workplace. Researchers want to see if screening this high-risk group works well, is organized properly, and helps people quit smoking.
Workers exposed to certain workplace chemicals face a higher risk of lung cancer, especially if they also smoke. Doctors want to know if regular screening with safe, low-dose lung scans can catch cancer early—when it's easier to treat—and whether it encourages people to quit smoking.
You likely qualify if…
You likely don't qualify if…
If you join, you would complete a questionnaire about your work history and smoking, then receive a low-dose lung scan to look for early signs of cancer. The study follows you for up to three years, checking on your health, whether you've quit smoking, and any changes in your condition. Regular visits and follow-up calls would track your progress and well-being over this time.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France